🚀 VC round data is live in beta, check it out!
Carvolix Valuation Multiples
Discover revenue and EBITDA valuation multiples for Carvolix and similar public comparables like JETEMA Co., Sisram Medical, 908 Devices, Quanterix and more.
Carvolix Overview
About Carvolix
Carvolix SA specializes in the development of AI-based mini-robots and biomimetic implants designed to autonomously replace heart valves and treat strokes.
Founded
2018
HQ
Employees
67
Website
Financials (LTM)
EV
$259M
Carvolix Financials
Carvolix reported last 12-month revenue of $663K and negative EBITDA of ($19M).
In the same LTM period, Carvolix generated ($19M) in EBITDA losses and had net loss of ($23M).
Revenue (LTM)
Carvolix P&L
In the most recent fiscal year, Carvolix reported revenue of $5M and EBITDA of ($12M).
Carvolix expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $663K | XXX | $5M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $988K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 21% | XXX | XXX | XXX |
| EBITDA | ($19M) | XXX | ($12M) | XXX | XXX | XXX |
| EBITDA Margin | (2802%) | XXX | (256%) | XXX | XXX | XXX |
| EBIT Margin | (3312%) | XXX | (355%) | XXX | XXX | XXX |
| Net Profit | ($23M) | XXX | ($16M) | XXX | XXX | XXX |
| Net Margin | (3474%) | XXX | (341%) | XXX | XXX | XXX |
| Net Debt | — | — | $17M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Carvolix Stock Performance
Carvolix has current market cap of $239M, and enterprise value of $259M.
Market Cap Evolution
Carvolix's stock price is $4.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $259M | $239M | 0.1% | XXX | XXX | XXX | $-0.27 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCarvolix Valuation Multiples
Carvolix trades at 390.0x EV/Revenue multiple, and (13.9x) EV/EBITDA.
EV / Revenue (LTM)
Carvolix Financial Valuation Multiples
As of March 29, 2026, Carvolix has market cap of $239M and EV of $259M.
Equity research analysts estimate Carvolix's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Carvolix has a P/E ratio of (10.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $239M | XXX | $239M | XXX | XXX | XXX |
| EV (current) | $259M | XXX | $259M | XXX | XXX | XXX |
| EV/Revenue | 390.0x | XXX | 54.4x | XXX | XXX | XXX |
| EV/EBITDA | (13.9x) | XXX | (21.2x) | XXX | XXX | XXX |
| EV/EBIT | (11.8x) | XXX | (15.3x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 261.8x | XXX | XXX | XXX |
| P/E | (10.4x) | XXX | (14.7x) | XXX | XXX | XXX |
| EV/FCF | (13.7x) | XXX | (33.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Carvolix Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Carvolix Margins & Growth Rates
Carvolix's revenue in the last 12 month grew by 437%.
Carvolix's revenue per employee in the last FY averaged $0.0M.
Carvolix's rule of 40 is (2365%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Carvolix's rule of X is (1710%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Carvolix Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 437% | XXX | (94%) | XXX | XXX | XXX |
| EBITDA Margin | (2802%) | XXX | (256%) | XXX | XXX | XXX |
| EBITDA Growth | 35% | XXX | 36% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (2365%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (1710%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 376% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Carvolix Public Comps
See public comps and valuation multiples for other Medical Devices and Autonomous AI & Robotics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| JETEMA Co. | XXX | XXX | XXX | XXX | XXX | XXX |
| Sisram Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| 908 Devices | XXX | XXX | XXX | XXX | XXX | XXX |
| Quanterix | XXX | XXX | XXX | XXX | XXX | XXX |
| CapsoVision | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Carvolix M&A Activity
Carvolix acquired XXX companies to date.
Last acquisition by Carvolix was on XXXXXXXX, XXXXX. Carvolix acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Carvolix
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCarvolix Investment Activity
Carvolix invested in XXX companies to date.
Carvolix made its latest investment on XXXXXXXX, XXXXX. Carvolix invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Carvolix
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Carvolix
| When was Carvolix founded? | Carvolix was founded in 2018. |
| Where is Carvolix headquartered? | Carvolix is headquartered in France. |
| How many employees does Carvolix have? | As of today, Carvolix has over 67 employees. |
| Is Carvolix publicly listed? | Yes, Carvolix is a public company listed on Euronext Paris. |
| What is the stock symbol of Carvolix? | Carvolix trades under CVX ticker. |
| When did Carvolix go public? | Carvolix went public in 2021. |
| Who are competitors of Carvolix? | Carvolix main competitors are JETEMA Co., Sisram Medical, 908 Devices, Quanterix. |
| What is the current market cap of Carvolix? | Carvolix's current market cap is $239M. |
| What is the current revenue of Carvolix? | Carvolix's last 12 months revenue is $663K. |
| What is the current revenue growth of Carvolix? | Carvolix revenue growth (NTM/LTM) is 437%. |
| What is the current EV/Revenue multiple of Carvolix? | Current revenue multiple of Carvolix is 390.0x. |
| Is Carvolix profitable? | No, Carvolix is not profitable. |
| What is the current EBITDA of Carvolix? | Carvolix has negative EBITDA and is not profitable. |
| What is Carvolix's EBITDA margin? | Carvolix's last 12 months EBITDA margin is (2802%). |
| What is the current EV/EBITDA multiple of Carvolix? | Current EBITDA multiple of Carvolix is (13.9x). |
| What is the current FCF of Carvolix? | Carvolix's last 12 months FCF is ($19M). |
| What is Carvolix's FCF margin? | Carvolix's last 12 months FCF margin is (2856%). |
| What is the current EV/FCF multiple of Carvolix? | Current FCF multiple of Carvolix is (13.7x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.